(Q44551608)

4 December 2017

title

Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus (English)

1 reference

4 December 2017

1 reference

3

Hector F DeLuca

1 reference

4 December 2017

Julia B Zella

1

1 reference

4 December 2017

Laura C McCary

series ordinal

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Archives of Biochemistry and Biophysics

4 December 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 December 2017

volume

417

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

77-80

1 reference

Current understanding of the molecular actions of vitamin D.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

The vitamin D receptor--structure and transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

Biological activity of 25-hydroxyergocalciferol in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

A Seasonal Variation Study of 25-Hydroxyvitamin D3Serum Levels in Normal Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900338-2

10.1016/S0003-9861(03)00338-2

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference